Transplanted neural stem cells hold promise for reducing the destruction of dopaminergic cells that occurs in Parkinson's disease and for replacing cells lost to the disease, scientists say. Research published in the current issue of The J...

The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine hav...

Gliomas are extremely malignant and fast growing tumors. Not only do they secrete molecules to secure their blood supply by generating blood vessels, they are also able to secrete messenger molecules to protect themselves against attac...

Gloria Lenhoff, age 51, can't make change for a dollar, or subtract five from twelve, or tell left from right. She can't cross the street alone, or write her name legibly, or read music. Her IQ is 55. But Gloria Lenhoff can sing like few p...

The Midwest Children's Brain Tumor Center at Advocate Lutheran General Children's Hospital awarded John Hipchen, President of the Board of Directors of the American Brain Tumor Association (ABTA), the Center's Wings of Hope Medal. This awa...

A small study on people identified as high risk for schizophrenia because two or more family members had the illness suggests certain changes occur in brain structure prior to onset. Scientists used magnetic resonance imaging (MRI) to moni...

Children who were exposed prenatally to the insecticide chlorpyrifos had significantly poorer mental and motor development by three years of age and increased risk for behavior problems, according to a peer-reviewed study published by the...

A small study on people identified as high risk for schizophrenia because two or more family members had the illness suggests certain changes occur in brain structure prior to onset. Scientists used magnetic resonance imaging (MRI) to moni...

The Roskamp Institute announced today its participation in a pharmaceutical sponsored research study for relapsing-remitting Multiple Sclerosis (MS) sufferers. While the Roskamp Institute's primary focus is on Alzheimer's disease, Roskamp...

Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company focused on commercializing its proprietary cellular energy modulation technology, announced today that the company has signed an agreement with the National...